Why it matters
An Iranian knowledge-based company has successfully localized the production of a blood bag tube sealer at one-third the cost of its foreign counterparts. The device ensures high-speed, precise, and high-quality sealing, marking a significant advancement in Iran’s medical technology sector.
What he is saying
Alireza Ahmadi, CEO of the company, emphasized that the HTS100 model was entirely designed and developed by Iranian specialists over four years. He highlighted its cold-sealing mechanism using radiofrequency (RF) technology at 40.67 MHz, preventing the formation of micro-clots that could compromise blood quality.
Key points
The HTS100 blood bag tube sealer is fully localized and costs one-third of similar foreign models.
Uses radiofrequency (RF) sealing instead of heat to prevent blood clotting inside the bag.
Can seal tubes in under one second with a 100-watt RF generator.
The company has an annual production capacity of 500 units and offers after-sales services, giving it a competitive edge over foreign alternatives.
Go deeper
Iran has been expanding its knowledge-based economy, particularly in medical device manufacturing, to reduce reliance on imports. This development aligns with the country's strategy to enhance domestic innovation and bolster healthcare resilience in response to international sanctions and supply chain challenges.
206
